Kaiku Health raised €4.4M in a Series A round in Feb 2018. The company is based in Helsinki, Finland. Investors in the round: and Athensmed., Debiopharm Innovation Fund SA and Tesi, Metsola Ventures. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €4.4M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
